Kisqali

Indicated For

Breast cancer

About This Medication

# Novartis Patient Assistance Program Patient Guide: How to Get Kisqali (ribociclib) at Low or No Cost Kisqali (ribociclib) is a prescription medication used to treat certain types of advanced or metastatic breast cancer in adults, often combined with other therapies like hormone treatments. The **Novartis Patient Assistance Program** (including Novartis Patient Support and the Novartis Patient Assistance Foundation, or NPAF) helps eligible patients access Kisqali at low or no cost through options like free medication, copay assistance, and bridge programs.[1][2][3] ## About Kisqali and Why Assistance Matters **Kisqali** is a targeted therapy known as a CDK4/6 inhibitor that helps slow the growth of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer cells. It's typically taken orally in cycles, alongside drugs like letrozole or fulvestrant, under close medical supervision due to potential side effects like low white blood cell counts, fatigue, and liver issues. Treatment costs can exceed thousands per month without help, making patient assistance crucial for many.[1][2][6] Novartis offers a suite of programs under **Novartis Patient Support**: - **Copay assistance**: Reduces out-of-pocket costs to as low as $0-$25/month for commercially insured patients, up to $15,000 annually.[2][10] - **Bridge Program**: Provides up to 5 months of free Kisqali for patients with private insurance facing prior authorization (PA) denials or delays.[1][4][6] - **Patient Assistance Foundation (NPAF/PAP)**: Free medication for low-income, uninsured, or underinsured patients meeting income guidelines.[3][9] These programs aim to help you start, stay on, and save on Kisqali without interruptions.[4] ## Who Qualifies? Eligibility varies by program: - **Copay Program**: Commercially insured U.S. patients (not Medicare, Medicaid, or government insurance). Automatic annual re-enrollment.[10] - **Bridge Program**: Private insurance with PA denial; must submit PA/appeal within 90 days. Up to 5 months free or until coverage approval.[1][2][4] - **NPAF/PAP**: Low-income patients (uninsured/underinsured). Must meet income requirements (vary by product, household size, and Federal Poverty Level—typically <400-500% FPL, but confirm specifics). Proof of Extra Help denial if applicable.[3][9] **Income Eligibility Breakdown** | Household Size | Estimated Max Annual Income (300% FPL)* | Notes | |---------------|---------------------------------------|-------| | Individual | ~$45,180 | Varies by program; attach proof like tax returns, pay stubs.[3][9] | | Couple | ~$61,320 | Household size includes dependents.[9] | | Family of 3 | ~$77,460 | NPAF requires full documentation.[3] | | Family of 4 | ~$93,600 | May adjust for state; call to verify.[9] | *Estimates based on 2026 FPL guidelines; actual thresholds 'may vary by product and household size.' Contact 866-433-8000 for exact figures.[3] ## Insurance Requirements - **Commercial/Private Insurance**: Required for copay and Bridge Programs. Submit front/back of insurance cards. Medicare/Medicaid patients generally ineligible for copay but may qualify for NPAF with proof of denial.[1][5][10] - **Uninsured/Underinsured**: Eligible for NPAF if income-qualified.[3] - **PA Requirements**: For Bridge, include PA denial/appeal submission within 90 days.[1][4] If insured but coverage is denied, Novartis helps with benefits verification, PA support, and appeals.[4] ## Step-by-Step Application Process 1. **Discuss with Your Doctor**: Get a valid Kisqali prescription. Your healthcare provider (HCP) must complete parts of the form.[1][9] 2. **Choose Enrollment Method**: - **Online**: Visit support.kisqali.com or pap.novartis.com; enter info securely.[2][3][6] - **Phone**: Call 866-433-8000 (Mon-Fri, 8 AM-8 PM ET) for help signing up.[1][6] - **Fax Form**: Download Start Form or Service Request Form; complete patient/HCP sections, fax to 800-414-3518 or 1-888-891-4924.[1][9] 3. **Gather Documents**: - Prescription details (drug, dose).[9] - Insurance cards (front/back).[1][5] - Proof of income (pay stubs, tax returns—copies only).[9] - PA/appeal if applicable.[5] - Patient authorization signature.[1] 4. **Submit**: Fax, online, or mail. Incomplete forms delay processing.[1][3] 5. **Follow Up**: Opt-in for texts; expect confirmation.[3] Your dedicated Novartis team handles verification and support.[4] ## Timeline and Delivery - **Processing**: NPAF decisions within 4 weeks; incomplete apps get next-steps letter.[3] Bridge/copay faster via online/phone. - **Approval**: Free meds shipped to pharmacy/doctor (up to 5 months for Bridge).[4][6] - **Delivery**: Coordinated by Novartis; track via support line.[4] ## Alternatives if Denied - **Appeal**: Work with Novartis for insurance appeals/PA resubmission.[4] - **Other Programs**: Check Kisqali Care (800-282-7630) or PANO for oncology support.[7] - **Generic/Biosimilars**: None currently; explore patient access networks or state programs. - **Reapply**: Fix issues (e.g., income proof) and resubmit.[3] ## Disclaimer This guide is for informational purposes based on available program details as of 2026. Eligibility, terms, and availability can change; Novartis reserves rights to modify/discontinue. Always verify with Novartis Patient Support (866-433-8000) or your HCP. Not a substitute for medical/financial advice. Report side effects: 1-888-NOW-NOVA.[1][3]

Program information last verified: March 30, 2026